Literature DB >> 25359338

How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries?

Zhi Zhen Qin1, Madhukar Pai1, Wayne Van Gemert2, Suvanand Sahu3, Marzieh Ghiasi1, Jacob Creswell4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25359338     DOI： 10.1183/09031936.00147714

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  30 in total

1.  Rapid Accurate Identification of Tuberculous Meningitis Among South African Children Using a Novel Clinical Decision Tool.

Authors:  Anu Goenka; Prakash M Jeena; Koleka Mlisana; Tom Solomon; Kevin Spicer; Rebecca Stephenson; Arpana Verma; Barnesh Dhada; Michael J Griffiths
Journal:  Pediatr Infect Dis J       Date:  2018-03       Impact factor: 2.129

Review 2.  TB control: challenges and opportunities for India.

Authors:  Madhukar Pai; Amrita Daftary; Srinath Satyanarayana
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-03       Impact factor: 2.184

3.  Current state of the art in rapid diagnostics for antimicrobial resistance.

Authors:  Rathina Kumar Shanmugakani; Balaji Srinivasan; Marshall J Glesby; Lars F Westblade; Washington B Cárdenas; Tony Raj; David Erickson; Saurabh Mehta
Journal:  Lab Chip       Date:  2020-07-09       Impact factor: 6.799

4.  Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting.

Authors:  Lesley Scott; Anura David; Lyndel Govender; Jan Furrer; Modiehi Rakgokong; Ziyaad Waja; Neil Martinson; Gabriel Eisenberg; Elizabeth Marlowe; Wendy Stevens
Journal:  J Mol Diagn       Date:  2020-08-01       Impact factor: 5.568

5.  Implementation of Xpert MTB/RIF in 22 high tuberculosis burden countries: are we making progress?

Authors:  Danielle Cazabon; Anita Suresh; Collins Oghor; Zhi Zhen Qin; Sandra V Kik; Claudia M Denkinger; Madhukar Pai
Journal:  Eur Respir J       Date:  2017-08-31       Impact factor: 16.671

Review 6.  Diagnosis of opportunistic infections: HIV co-infections - tuberculosis.

Authors:  Lesley Scott; Pedro da Silva; Catharina C Boehme; Wendy Stevens; Christopher M Gilpin
Journal:  Curr Opin HIV AIDS       Date:  2017-03       Impact factor: 4.283

7.  Testing Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries.

Authors:  Saddiq T Abdurrahman; Omezikam Mbanaso; Lovett Lawson; Olanrewaju Oladimeji; Matthew Blakiston; Joshua Obasanya; Russell Dacombe; Emily R Adams; Nnamdi Emenyonu; Suvanand Sahu; Jacob Creswell; Luis E Cuevas
Journal:  J Clin Microbiol       Date:  2015-05-27       Impact factor: 5.948

8.  Infection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the Key.

Authors:  Gilles van Cutsem; Petros Isaakidis; Jason Farley; Ed Nardell; Grigory Volchenkov; Helen Cox
Journal:  Clin Infect Dis       Date:  2016-05-15       Impact factor: 9.079

Review 9.  Target product profile of a molecular drug-susceptibility test for use in microscopy centers.

Authors:  Claudia M Denkinger; David Dolinger; Marco Schito; William Wells; Frank Cobelens; Madhukar Pai; Matteo Zignol; Daniela Maria Cirillo; David Alland; Martina Casenghi; Jim Gallarda; Catharina C Boehme; Mark D Perkins
Journal:  J Infect Dis       Date:  2015-04-01       Impact factor: 5.226

10.  Testing and treating the missing millions with tuberculosis.

Authors:  Madhukar Pai; Puneet Dewan
Journal:  PLoS Med       Date:  2015-03-24       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.